Journals / Clinical and Experimental Health Sciences / 2020 / Cilt: 10 - Sayı: 3

Opinions and Experiences of Patients Receiving Oral Chemotherapy: A Qualitative Study

Pages
265–271
Publication Date
2020-09-29
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion:In this process, it is crucial that nurses take an active role in patient education and counselling among health professionals so that weaknesses in the patient's drug use process and opportunities for improvement could be identified.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aim: This study is a qualitative study aimed to determine the opinions and experiences of patients receiving oral chemotherapy.
📊
Key Findings & Data:Methods: The study was conducted in January 2018 with 18 volunteers who applied to oncology polyclinic at a university hospital and received oral chemotherapy.
💡
Conclusion & Impact:Conclusion:In this process, it is crucial that nurses take an active role in patient education and counselling among health professionals so that weaknesses in the patient's drug use process and opportunities for improvement could be identified.
🔬Design:Research Article
📍Scope:2018 Verileri
⚙️Variables:Oral chemotherapy agents · patient · qualitative study

Abstract

Aim: This study is a qualitative study aimed to determine the opinions and experiences of patients receiving oral chemotherapy. Methods: The study was conducted in January 2018 with 18 volunteers who applied to oncology polyclinic at a university hospital and received oral chemotherapy. In data collection, a description form and a semi-structured interview form were administered. In data analysis process, transcription after each interview and evaluation steps through thematic content analysis method were employed. Results: The themes obtained in the study are as access to drugs, use of medicine, side effects and control of treatment, approach of health professionals and support of family and relatives. There is a need to ensure the continuity of the treatment follow-up period in order to improve treatment compliance of patients, to monitor side effects of treatment and to ensure safe use of medicines. Conclusion:In this process, it is crucial that nurses take an active role in patient education and counselling among health professionals so that weaknesses in the patient's drug use process and opportunities for improvement could be identified.

🔖

Cite This Article

KUTLUTÜRKAN, S., KIRCA, K., YURTAL, Ö. (2020). Opinions and Experiences of Patients Receiving Oral Chemotherapy: A Qualitative Study. Clinical and Experimental Health Sciences, Cilt: 10 - Sayı: 3, 265–271. https://ajindex.com/articles/481449

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (7)

  1. Özkaraman A, Orlu N, Atalay H, Babadağ B, Yılmaz H, Dinçer M, Alparslan G.B. Assessment of problems and medication adherence of patients taking oral chemotherapy Medical Journal of Bakırköy. 2017;13: 91-97. https://doi: 10.5350/BTDMJB201713206 (Turkish
  2. Bedell CH. Changing Paradigm for Cancer Treatment: The Advent of New Oral Chemotherapy Agents. Clinical Journal of Oncology Nursing. 2003;7:5–9.https://doi: 10.1188/03.CJON.S6.5-9 [3] Kav S, Schulmeister L, Nirenberg A, Barber L, Johnson J, Rittenberg C. Development of the MASCC teaching tool for patients receiving oral agents for cancer. Support Care Cancer. 2010;18:583-590. https://doi: 10.1007/s00520-009-0692-5 [4] Wu EQ, Johnson S, Beaulieu N, Arana M, Bollu V, Guo A et al. Healthcare resource utilization and costs associated with non-adherence to imatinib treatment in chronic myeloid leukemia patients. Curr Med Res Opin. 2010;26:61-69. https://doi: 10.1185/03007990903396469
  3. Collins CM, Elsaid KA. Using an enhanced oral chemotherapy computerized provider order entry system to reduce prescribing errors and improve safety. Int J Qual Health Care. 2011;23:36-43. https:// doi: 10.1093/intqhc/mzq066
  4. Kav S, Bostancı H. Role of the nurse in patient education and follow up of people receiving oral chemotherapy treatment in Turkey. Support Care Cancer. 2006; 14: 1252-1257. https:// doi: 10.1007/s00520-007-0377-x [7] Barillet M, Prevost V, Joly F, Clarisse B. Oral antineoplastic agents: How do we care about adherence? Br J Clin Pharmacol. 2015; 80:1289-1302. https://doi: 10.1111/bcp.12734 [8] Bettencourt E. Oral Chemotherapy– What Your Patıents Need To Know. 2014. Access date: 08.01.2018
  5. Moody M, Jackowski J. Are patients on oral chemotherapy in your practice setting safe? Clin J Oncol Nurs. 2010;14:339-346.
  6. Wood L. A review on adherence management in patients on oral cancer therapies. European Journal of Oncology Nursing. 2012;16:432-438. https://doi: 10.1016/j.ejon.2011.10.002 [11] Ruddy K, Mayer E, Partridge A. Patient adherence and persistence with oral anticancer treatment. CA Cancer J Clin. 2009; 59: 56-66. https://doi: 10.3322/caac.20004
  7. Johnson PE, Chambers CR, Vaida AJ. Oncology medication safety: A 3D status report 2008. J Oncol Pharm Pract. 2008;14:169– 180. https://doi: 10.1177/1078155208097634 [13] Chan A, Leow YC, Sim H. Patients' perspectives and safe handling of oral anticancer drugs at an Asian cance